April 18, 2013 at 12:05 PM EDT
Vivus: Why Options Traders are Betting on a Recovery Rally
Vivus (NASDAQ: VVUS) has been one of the most disappointing post-FDA approval investments in recent history, although options traders seem to think that the stock is finally going to see some big relief. As reported yesterday by Schaeffer’s: “VIVUS, Inc. (NASDAQ:VVUS) was trending higher on Tuesday, after the Food and Drug Administration (FDA) granted the firm [...]
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here